Title: The National Vaccine Plan Update: Recent Activities and Next Steps
1The National Vaccine Plan Update Recent
Activities and Next Steps
- Raymond A. Strikas, MD
- National Vaccine Program Office
- Department of Health and Human Services
- June 7, 2007
2Presentation Outline
- Process to date
- March 20, 2007 interagency meeting
- Discussions with Assistant Secretary for Health
- Review of WHO, Canada, UK, New Zealand strategic
vaccine plans - June 05, 2007 interagency meeting
- Review of the priorities received to date
- DHHS Agencies, offices, and DoD
- Process forward
3Recommendations from 03/20/07 Interagency Meeting
- 1
- Incorporate HP 2010 objectives
- Consider public health infrastructure
- Provide and review ODPHP/HealthyPeople 2010
guidance document - Evaluate 1994 plan with the stake in the ground
approach. - Use evaluation to identify gaps.
- Create a National Plan as opposed to a federal
government plan.
4Recommendations from 03/20/07 Interagency Meeting
- 2
- Extend timelines to include stakeholders
engagement - Determine level for stakeholders involvment
- Develop straw man document for stakeholders
- Identify main purpose of the plan.
- Catalogue existing documents to help identify
gaps - Agencies should identify 5 to10 gaps
5Results of Subsequent Discussion with Assistant
Secretary for Health - 1
- Purpose of updated Plan
- Engage in a process, with govt and non-govt
stakeholders, to define challenges and
opportunities, and thence goals. - Identify steps to achieve the goals
- Process should be deliberate and may require 3 or
more budget cycles - Begin that involvement now to define challenges
and priorities, to lead to goals - Look at diseases for which we do not have
vaccines, and ask why not, as well as look for
opportunities to improve current vaccines (e.g.,
what can adjuvants do?), e.g., - improved bio-defense vaccines
- pandemic preparedness
- HIV
- TB
- Malaria
- The updated plan should also include reference to
- Vaccine research and development
- Financing
- Safety
- Supply and Distribution
6Results of Subsequent Discussion with Assistant
Secretary for Health - 2
- Process should reference the Healthy People (HP)
2020 objectives where possible, as well as the HP
2010 objectives - Plans goals should define funding needs, but not
have available funds or budget define possible
goals -
7WHO Global Immunization Vision and Strategy
Goals, 2006-2015
- Increase, then sustain coverage
- Reduce measles mortality by 2010
- Reduce morbidity and mortality in children
- Ensure access to vaccines of assured quality
- Introduce new vaccines (and offer to all eligible
within 5 years of introduction) - Ensure capacity for surveillance and monitoring
- Strengthen systems (integrate with other health
services) - Assure sustainability
8Other Countries Priorities Canadas 2003
National Immunization Strategy Goals
- Provide high, achievable and measurable coverage
of publicly funded immunization programs for all
Canadians. - Provide complete coverage of all children with
routine childhood vaccines recommended by the
proposed national immunization committee. - Ensure equitable access to these routinely
recommended vaccines - among jurisdictions and in
special populations - while considering
jurisdictional program implementation
differences. - Promote public and professional acceptance of
recommended programs. - Provide optimal program safety, effectiveness and
acceptance. - Improve coordination and efficiency.
- Provide optimal cost-effectiveness and
affordability of programs. - Ensure security of vaccine supplies.
- Provide national intervention when required.
alludes to Canadas federal system
9Other Countries Priorities Canadas National
Immunization Strategy Components
- Immunization program planning to support
collaborative, national assessment and
prioritization of new vaccines, using common
criteria. - Vaccine safety to optimize the vaccine safety
system, maintain professional and public
confidence in the safety of vaccines, and address
growing anti-immunization concerns - Vaccine procurement to ensure the best value for
vaccines, the long-term security of supply for
vaccines, the quality of supply, and improvements
in accountability. - Immunization registry network to
- Enhance national surveillance of immunization
coverage rates - Facilitate transfer of and access to individual
immunization records. - Measure progress towards national immunization
goals and objectives. - Facilitate linkage of surveillance data of
vaccine preventable diseases and
vaccine-associated adverse events (VAAEs).
10Other Countries PrioritiesUK 2002 Strategy for
Combating Infectious Diseases
- Extending the use of existing vaccines to larger
numbers of people - in particular influenza
vaccine and pneumococcal vaccine - Continuing to maintain high levels of coverage in
the childhood immunisation programmes - Switching from oral polio immunisation to the
injected form when global progress on polio
eradication is at an appropriate point - Introducing available and soon to be available
vaccines according to epidemiological needs and
cost effectiveness, e.g. varicella vaccine,
pneumococcal conjugate vaccine - Stepping up research and investment to bring
forward new vaccines to prevent large or serious
infectious disease problems, in particular
meningococcal Group B vaccine, a vaccine against
respiratory syncitial virus (one of the commonest
causes of chest infection and hospital admission)
and rotavirus gastroenteritis - Contributing to international research to develop
a vaccine against HIV infection - Establishing a system to track vaccines using new
technologies such as bar-coding - Designing new materials for the public and
parents on vaccines which will be address their
needs for information and will be made as widely
accessible as possible through opportunities such
as the internet.
11Other Countries PrioritiesImmunisation in New
Zealand Strategic Directions 2003 - 2006
- implement the National Immunisation Register, as
a critical supporting tool for vaccinators, DHBs
and the NIP and as a basis for further
implementation of electronic collection of Well
Child information over time - achieve a significant reduction in meningococcal
B disease, through introduction of the MeNZB
vaccine in 2004/05 (subject to licensure) - improve access to immunisation services in
primary care and outreach settings to reduce
inequalities in immunisation coverage (and thus
the risk of vaccine-preventable disease),
prioritising equitable coverage for Maori and
Pacific peoples - develop an effective communication and promotion
strategy for immunisation as a key component of
child and adult health.
12Interagency Meeting 06/05/07
- Review and revision of priority Areas and Issues
- Review and revision of Lead and Contributing
Agencies - Discussion of stakeholder involvement
- Agreement on next steps
13Priorities - 1
- Received from many, agencies and offices
- More to come
- Summary tables
- Developed to include all items received
- Reviewed at 06/05 interagency meeting
- Revision in progress
14Priorities - 2
- Sorted according to goals of 1994 Plan
- Develop new and improved vaccines
- Ensure safety and effectiveness
- Better educate public and health professionals
- Achieve better use of existing vaccines
- Further sorted to Areas and Issues
- E.g., Manufacture and Supply
- Surge capacity/rapid response
- Oversight
- Domestic Capacity
- Stability of vaccine supply
15 Priorities - 3
- For planning purposes
- Lead agency/agencies
- E.g., FDA
- Contributing agencies
- E.g., CDC
16Next Steps -- Priorities
- Lead, contributing agencies, NVPO
- Identify/develop actions for each issue
- 2010 milestones
- 2020 milestones?
- Draft discussion document
- Establish Task Force to do this
17Stakeholder Involvement Current Thoughts on
Approach
- Complete priorities table with introduction and
annotation - National Vaccine Advisory Committee review and
comments - Engage other expert stakeholders process of
engagement being determined - Engage broader groups of stakeholders, including
the general public
18Stakeholder InvolvementNext Steps
- NVPO develops draft priorities document for
interagency review and comment - NVAC review of document
- Implementation of stakeholder engagement
19Further Comments
- NVPO (Drs. Gellin, Tardif)
- NVAC (Dr. Hinman)
- Interagency group participants
- NVAC discussion